Zobrazeno 1 - 10
of 2 065
pro vyhledávání: '"Montal R"'
Autor:
Cappuyns S; Digestive Oncology, Department of Gastroenterology, University Hospitals Leuven, Leuven, Belgium; Laboratory of Clinical Digestive Oncology, Department of Oncology, KU Leuven, Leuven, Belgium; Laboratory for Translational Genetics, Department of Human Genetics, KU Leuven, Leuven, Belgium; VIB Centre for Cancer Biology, Leuven, Belgium; Mount Sinai Liver Cancer Program (Divisions of Liver Diseases, Department of Hematology/Oncology, Department of Medicine), Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, USA., Piqué-Gili M; Mount Sinai Liver Cancer Program (Divisions of Liver Diseases, Department of Hematology/Oncology, Department of Medicine), Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, USA; Liver Cancer Translational Research Laboratory, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic, Universitat de Barcelona, Barcelona, Catalonia, Spain., Esteban-Fabró R; Mount Sinai Liver Cancer Program (Divisions of Liver Diseases, Department of Hematology/Oncology, Department of Medicine), Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, USA; Liver Cancer Translational Research Laboratory, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic, Universitat de Barcelona, Barcelona, Catalonia, Spain., Philips G; Laboratory for Translational Genetics, Department of Human Genetics, KU Leuven, Leuven, Belgium; VIB Centre for Cancer Biology, Leuven, Belgium., Balaseviciute U; Liver Cancer Translational Research Laboratory, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic, Universitat de Barcelona, Barcelona, Catalonia, Spain., Pinyol R; Liver Cancer Translational Research Laboratory, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic, Universitat de Barcelona, Barcelona, Catalonia, Spain., Gris-Oliver A; Liver Cancer Translational Research Laboratory, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic, Universitat de Barcelona, Barcelona, Catalonia, Spain., Vandecaveye V; Radiology Department, University Hospitals Leuven, Leuven, Belgium; Laboratory of Translational MRI, Department of Imaging and Pathology, KU Leuven, Leuven, Belgium., Abril-Fornaguera J; Mount Sinai Liver Cancer Program (Divisions of Liver Diseases, Department of Hematology/Oncology, Department of Medicine), Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, USA; Liver Cancer Translational Research Laboratory, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic, Universitat de Barcelona, Barcelona, Catalonia, Spain., Montironi C; Liver Cancer Translational Research Laboratory, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic, Universitat de Barcelona, Barcelona, Catalonia, Spain; Pathology Department and Molecular Biology Core, Hospital Clínic of Barcelona, Barcelona, Spain., Bassaganyas L; Institut de Génomique Fonctionnelle, Univ. Montpellier, CNRS, INSERM, Montpellier, France., Peix J; Liver Cancer Translational Research Laboratory, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic, Universitat de Barcelona, Barcelona, Catalonia, Spain., Zeitlhoefler M; Mount Sinai Liver Cancer Program (Divisions of Liver Diseases, Department of Hematology/Oncology, Department of Medicine), Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, USA., Mesropian A; Mount Sinai Liver Cancer Program (Divisions of Liver Diseases, Department of Hematology/Oncology, Department of Medicine), Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, USA; Liver Cancer Translational Research Laboratory, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic, Universitat de Barcelona, Barcelona, Catalonia, Spain., Huguet-Pradell J; Mount Sinai Liver Cancer Program (Divisions of Liver Diseases, Department of Hematology/Oncology, Department of Medicine), Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, USA; Liver Cancer Translational Research Laboratory, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic, Universitat de Barcelona, Barcelona, Catalonia, Spain., Haber PK; Department of Surgery, Campus Charité Mitte and Campus Virchow-Klinikum, Charité-Universitätsmedizin Berlin, 13353 Berlin, Germany., Figueiredo I; Department of Immunology and Immunotherapy, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Ioannou G; Department of Immunology and Immunotherapy, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Gonzalez-Kozlova E; Department of Immunology and Immunotherapy, Icahn School of Medicine at Mount Sinai, New York, NY, USA., D'Alessio A; Department of Surgery & Cancer, Imperial College London, Hammersmith Hospital, London, United Kingdom., Mohr R; Department of Hepatology and Gastroenterology, Charité - Universitätsmedizin Berlin, Campus Virchow Klinikum (CVK) and Campus Charité Mitte (CCM), Berlin, Germany., Meyer T; Research Department of Oncology, UCL Cancer Institute, University College London, Royal Free Hospital, London, UK., Lachenmayer A; Department of Visceral Surgery and Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland., Marquardt JU; Department of Medicine I, University Medical Center Schleswig Holstein Campus Lübeck, Lübeck, Germany., Reeves HL; Newcastle University Translational and Clinical Research Institute and Newcastle University Centre for Cancer, Medical School, Framlington Place, Newcastle Upon Tyne, NE2 4HH, UK; Hepatopancreatobiliary Multidisciplinary Team, Newcastle upon Tyne NHS Foundation Trust, Freeman Hospital, Newcastle upon Tyne, UK., Edeline J; Department of Medical Oncology, Centre Eugène Marquis, Rennes, France., Finkelmeier F; Department of Gastroenterology, University Liver and Cancer Centre, Frankfurt, Germany., Trojan J; Department of Gastroenterology, University Liver and Cancer Centre, Frankfurt, Germany., Galle PR; Department of Medicine I, University Medical Center of the Johannes-Gutenberg University, Mainz, Germany., Foerster F; Department of Medicine I, University Medical Center of the Johannes-Gutenberg University, Mainz, Germany., Mínguez B; Liver Unit, Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain; Liver Diseases Research Group, Vall d'Hebron Institute of Research (VHIR), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain; CIBERehd, Universitat Autònoma de Barcelona, Barcelona, Spain., Montal R; Department of Medical Oncology, Cancer Biomarkers Research Group, Hospital Universitari Arnau de Vilanova, IRBLleida, University of Lleida (UdL), Catalonia, Spain., Gnjatic S; Department of Immunology and Immunotherapy, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Pinato DJ; Department of Surgery & Cancer, Imperial College London, Hammersmith Hospital, London, United Kingdom; Department of Surgery & Cancer, Imperial College London, Hammersmith Hospital, London, United Kingdom., Heikenwalder M; Division of Chronic Inflammation and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany., Verslype C; Digestive Oncology, Department of Gastroenterology, University Hospitals Leuven, Leuven, Belgium; Laboratory of Clinical Digestive Oncology, Department of Oncology, KU Leuven, Leuven, Belgium., Van Cutsem E; Digestive Oncology, Department of Gastroenterology, University Hospitals Leuven, Leuven, Belgium; Laboratory of Clinical Digestive Oncology, Department of Oncology, KU Leuven, Leuven, Belgium., Lambrechts D; Laboratory for Translational Genetics, Department of Human Genetics, KU Leuven, Leuven, Belgium; VIB Centre for Cancer Biology, Leuven, Belgium., Villanueva A; Mount Sinai Liver Cancer Program (Divisions of Liver Diseases, Department of Hematology/Oncology, Department of Medicine), Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, USA., Dekervel J; Digestive Oncology, Department of Gastroenterology, University Hospitals Leuven, Leuven, Belgium; Laboratory of Clinical Digestive Oncology, Department of Oncology, KU Leuven, Leuven, Belgium. Electronic address: jeroen.dekervel@uzleuven.be., Llovet JM; Mount Sinai Liver Cancer Program (Divisions of Liver Diseases, Department of Hematology/Oncology, Department of Medicine), Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, USA; Liver Cancer Translational Research Laboratory, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic, Universitat de Barcelona, Barcelona, Catalonia, Spain; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Catalonia, 08010, Spain. Electronic address: josep.llovet@mountsinai.org.
Publikováno v:
Journal of hepatology [J Hepatol] 2024 Dec 19. Date of Electronic Publication: 2024 Dec 19.
Autor:
Veas Rodríguez J; Department of Medical Oncology, Arnau de Vilanova University Hospital, Lleida, Spain; Department of Medical Oncology, Taunton and Somerset NHS Foundation Trust, Taunton, United Kingdom. Electronic address: Joelveas@gmail.com., Prieto A; Department of Medical Oncology, Arnau de Vilanova University Hospital, Lleida, Spain., Vilaprinyo E; Department of Basic Medical Sciences, University of Lleida, IRBLLEIDA, Lleida, Spain., Bonet M; Department of Radiation Oncology, Arnau de Vilanova University Hospital, Lleida, Spain., Diez M; Department of Medical Oncology, Vall d' Hebron University Hospital, Barcelona, Spain., Salud A; Department of Medical Oncology, Arnau de Vilanova University Hospital, Lleida, Spain., Montal R; Department of Medical Oncology, Arnau de Vilanova University Hospital, Lleida, Spain.
Publikováno v:
Critical reviews in oncology/hematology [Crit Rev Oncol Hematol] 2024 Oct; Vol. 202, pp. 104466. Date of Electronic Publication: 2024 Aug 10.
Autor:
Veas Rodríguez J; Department of Medical Oncology, Arnau de Vilanova University Hospital, Lleida, Spain; Department of Medical Oncology, Taunton and Somerset NHS Foundation Trust, Taunton, United Kingdom. Electronic address: joelveas@gmail.com., Prieto A; Department of Medical Oncology, Arnau de Vilanova University Hospital, Lleida, Spain., Vilaprinyo E; Department of Basic Medical Sciences, University of Lleida, IRBLLEIDA, Lleida, Spain., Bonet M; Department of Radiation Oncology, Arnau de Vilanova University Hospital, Lleida, Spain., Diez M; Department of Medical Oncology, Vall d' Hebron University Hospital, Barcelona, Spain., Salud A; Department of Medical Oncology, Arnau de Vilanova University Hospital, Lleida, Spain., Montal R; Department of Medical Oncology, Arnau de Vilanova University Hospital, Lleida, Spain.
Publikováno v:
Critical reviews in oncology/hematology [Crit Rev Oncol Hematol] 2024 Sep; Vol. 201, pp. 104416. Date of Electronic Publication: 2024 Jun 12.
Autor:
O'Rourke CJ; Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Department of Health and Medical Sciences, Copenhagen, Denmark., Salati M; Division of Oncology, Department of Oncology and Hematology, University Hospital Modena, Modena, Italy.; Clinical and Experimental Medicine, University of Modena and Reggio Emilia, Modena, Italy., Rae C; School of Cancer Sciences, University of Glasgow, Glasgow, UK., Carpino G; Department of Anatomical, Histological, Forensic Medicine and Orthopaedic Sciences, Sapienza University of Rome, Roma, Italy., Leslie H; School of Cancer Sciences, University of Glasgow, Glasgow, UK., Pea A; School of Cancer Sciences, University of Glasgow, Glasgow, UK., Prete MG; School of Cancer Sciences, University of Glasgow, Glasgow, UK., Bonetti LR; Division of Pathology, University of Modena and Reggio Emilia, Modena, Italy., Amato F; School of Cancer Sciences, University of Glasgow, Glasgow, UK., Montal R; Cancer Biomarkers Research Group, Department of Medical Oncology, Hospital Universitari Arnau de Vilanova, Lleida, Spain., Upstill-Goddard R; School of Cancer Sciences, University of Glasgow, Glasgow, UK., Nixon C; Cancer Research UK Beatson Cancer Research Institute, Glasgow, UK., Sanchon-Sanchez P; School of Cancer Sciences, University of Glasgow, Glasgow, UK., Kunderfranco P; Bioinformatics Unit, IRCCS Humanitas Research Hospital, Rozzano, Italy., Sia D; Liver Cancer Translational Research Laboratory, BCLC Group, Liver Unit and Pathology Department, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Gaudio E; Department of Anatomical, Histological, Forensic Medicine and Orthopaedic Sciences, Sapienza University of Rome, Roma, Italy., Overi D; Department of Anatomical, Histological, Forensic Medicine and Orthopaedic Sciences, Sapienza University of Rome, Roma, Italy., Cascinu S; Medical Oncology, IRCCS Humanitas Research Hospital, Milan, Italy., Hogdall D; Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Department of Health and Medical Sciences, Copenhagen, Denmark.; Department of Oncology, Herlev Hospital, Herlev, Denmark., Pugh S; Addenbrooke's Hospital, Cambridge, UK., Domingo E; Department of Oncology, University of Oxford, Oxford, UK., Primrose JN; Surgery, University of Southampton, Southampton, UK., Bridgewater J; Department of Oncology, University College London, London, UK., Spallanzani A; Division of Oncology, Department of Oncology and Hematology, University Hospital Modena, Modena, Italy., Gelsomino F; Division of Oncology, Department of Oncology and Hematology, University Hospital Modena, Modena, Italy., Llovet JM; Translational Research in Hepatic Oncology, Liver Unit, IDIBAPS, Hospital Clínic, University of Barcelona, Barcelona, Spain.; Icahn School of Medicine at Mount Sinai, New York, New York, USA.; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain., Calvisi DF; Institute of Pathology, University of Regensburg Faculty of Medicine, Regensburg, Germany.; Medical, Surgical, and Clinical Sciences, University of Sassari, Sassari, Italy., Boulter L; MRC HGU, The University of Edinburgh MRC Institute of Genetics and Molecular Medicine, Edinburgh, UK.; CRUK Scotland Cancer Centre, Glasgow-Edinburgh, UK., Caputo F; Division of Oncology, Department of Oncology and Hematology, University Hospital Modena, Modena, Italy., Lleo A; Department of Biomedical Sciences, Humanitas University, Milan, Italy.; Internal Medicine and Hepatology Unit, Department of Gastroenterology, IRCCS Humanitas Research Hospital, Milan, Italy., Jamieson NB; School of Cancer Sciences, University of Glasgow, Glasgow, UK.; CRUK Scotland Cancer Centre, Glasgow-Edinburgh, UK., Luppi G; Division of Oncology, Department of Oncology and Hematology, University Hospital Modena, Modena, Italy., Dominici M; Division of Oncology, Department of Oncology and Hematology, University Hospital Modena, Modena, Italy., Andersen JB; Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Department of Health and Medical Sciences, Copenhagen, Denmark chiara.braconi@glasgow.ac.uk jesper.andersen@bric.ku.dk., Braconi C; School of Cancer Sciences, University of Glasgow, Glasgow, UK chiara.braconi@glasgow.ac.uk jesper.andersen@bric.ku.dk.; CRUK Scotland Cancer Centre, Glasgow-Edinburgh, UK.; Beatson West of Scotland Cancer Centre, Glasgow, UK.
Publikováno v:
Gut [Gut] 2024 Feb 23; Vol. 73 (3), pp. 496-508. Date of Electronic Publication: 2024 Feb 23.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Parisi E; Research Group of Cancer Biomarkers, Biomedical Research Institute of Lleida (IRBLleida), 25198 Lleida, Spain.; Department of Experimental Medicine, University of Lleida, 25198 Lleida, Spain., Hidalgo I; Research Group of Cancer Biomarkers, Biomedical Research Institute of Lleida (IRBLleida), 25198 Lleida, Spain., Montal R; Research Group of Cancer Biomarkers, Biomedical Research Institute of Lleida (IRBLleida), 25198 Lleida, Spain.; Department of Medical Oncology, Arnau de Vilanova University Hospital (HUAV), 25198 Lleida, Spain.; Department of Basic Medical Sciences, University of Lleida and IRBLleida, 25198 Lleida, Spain., Pallisé O; Research Group of Cancer Biomarkers, Biomedical Research Institute of Lleida (IRBLleida), 25198 Lleida, Spain.; Department of Medical Oncology, Arnau de Vilanova University Hospital (HUAV), 25198 Lleida, Spain., Tarragona J; Department of Pathology and Molecular Genetics/Oncologic Pathology Group, Biomedical Research Institute of Lleida (IRBLleida), University of Lleida, CIBERONC, 25198 Lleida, Spain., Sorolla A; Research Group of Cancer Biomarkers, Biomedical Research Institute of Lleida (IRBLleida), 25198 Lleida, Spain., Novell A; Research Group of Cancer Biomarkers, Biomedical Research Institute of Lleida (IRBLleida), 25198 Lleida, Spain., Campbell K; School of Biosciences, The University of Sheffield, Sheffield S10 2TN, UK., Sorolla MA; Research Group of Cancer Biomarkers, Biomedical Research Institute of Lleida (IRBLleida), 25198 Lleida, Spain., Casali A; Department of Basic Medical Sciences, University of Lleida and IRBLleida, 25198 Lleida, Spain., Salud A; Research Group of Cancer Biomarkers, Biomedical Research Institute of Lleida (IRBLleida), 25198 Lleida, Spain.; Department of Medical Oncology, Arnau de Vilanova University Hospital (HUAV), 25198 Lleida, Spain.; Department of Medicine, University of Lleida, 25198 Lleida, Spain.
Publikováno v:
International journal of molecular sciences [Int J Mol Sci] 2023 Jun 30; Vol. 24 (13). Date of Electronic Publication: 2023 Jun 30.
Autor:
Ortiz-Barahona V; Cancer Epigenetics Group, Josep Carreras Leukaemia Research Institute, Badalona, Barcelona, Catalonia, 08916, Spain., Soler M; Cancer Epigenetics Group, Josep Carreras Leukaemia Research Institute, Badalona, Barcelona, Catalonia, 08916, Spain., Davalos V; Cancer Epigenetics Group, Josep Carreras Leukaemia Research Institute, Badalona, Barcelona, Catalonia, 08916, Spain., García-Prieto CA; Cancer Epigenetics Group, Josep Carreras Leukaemia Research Institute, Badalona, Barcelona, Catalonia, 08916, Spain.; Life Sciences Department, Barcelona Supercomputing Center (BSC), Barcelona, Catalonia, Spain., Janin M; Cancer Epigenetics Group, Josep Carreras Leukaemia Research Institute, Badalona, Barcelona, Catalonia, 08916, Spain., Setien F; Cancer Epigenetics Group, Josep Carreras Leukaemia Research Institute, Badalona, Barcelona, Catalonia, 08916, Spain., Fernández-Rebollo I; Cancer Epigenetics Group, Josep Carreras Leukaemia Research Institute, Badalona, Barcelona, Catalonia, 08916, Spain., Bech-Serra JJ; Proteomics Unit, Josep Carreras Leukaemia Research Institute, Badalona, Barcelona, Catalonia, 08916, Spain., De La Torre C; Proteomics Unit, Josep Carreras Leukaemia Research Institute, Badalona, Barcelona, Catalonia, 08916, Spain., Guil S; Regulatory RNA and Chromatin Group, Josep Carreras Leukaemia Research Institute, Badalona, Barcelona, Catalonia, 08916, Spain.; Germans Trias i Pujol Health Science Research Institute, Barcelona, Catalonia, Spain., Villanueva A; Chemoresistance and Predictive Factors Group, Program Against Cancer Therapeutic Resistance (ProCURE), Catalan Institute of Oncology (ICO), Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet del Llobregat, Barcelona, Catalonia, Spain., Zhang PH; Shanghai Institute of Nutrition and Health, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, China.; Center for Molecular Medicine, Children's Hospital, Fudan University and Shanghai Key Laboratory of Medical Epigenetics, International Laboratory of Medical Epigenetics and Metabolism, Institutes of Biomedical Sciences, Fudan University, Shanghai, China., Yang L; Center for Molecular Medicine, Children's Hospital, Fudan University and Shanghai Key Laboratory of Medical Epigenetics, International Laboratory of Medical Epigenetics and Metabolism, Institutes of Biomedical Sciences, Fudan University, Shanghai, China., Guarnacci M; Shine-Dalgarno Centre for RNA Innovation, Australian National University, Canberra, Australia., Schumann U; Shine-Dalgarno Centre for RNA Innovation, Australian National University, Canberra, Australia., Preiss T; Shine-Dalgarno Centre for RNA Innovation, Australian National University, Canberra, Australia.; Victor Chang Cardiac Research Institute, Darlinghurst (Sydney), Queensland, NSW, 2010, Australia., Balaseviciute U; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic, University of Barcelona, Catalonia, Spain., Montal R; Hospital Arnau de Vilanova, IRBLleida, University of Lleida (UdL), Catalonia, Spain., Llovet JM; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic, University of Barcelona, Catalonia, Spain.; ICAHN School of Medicine at Mount Sinai, New York, NY, USA.; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Catalonia, 08010, Spain., Esteller M; Cancer Epigenetics Group, Josep Carreras Leukaemia Research Institute, Badalona, Barcelona, Catalonia, 08916, Spain. mesteller@carrerasresearch.org.; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Catalonia, 08010, Spain. mesteller@carrerasresearch.org.; Centro de Investigacion Biomedica en Red Cancer, Madrid, 28029, Spain. mesteller@carrerasresearch.org.; Physiological Sciences Department, School of Medicine and Health Sciences, University of Barcelona, Barcelona, Catalonia, 08907, Spain. mesteller@carrerasresearch.org.
Publikováno v:
Molecular cancer [Mol Cancer] 2023 May 12; Vol. 22 (1), pp. 83. Date of Electronic Publication: 2023 May 12.
Publikováno v:
In Annals of Oncology June 2023 34 Supplement 1:S83-S83
Autor:
Veas, J., Piñol, M., Sorolla, M., Parisi, E., Sorolla, A., Santacana, M., Ruiz, M., Parra, G., Aracil, C., Escartin, A., Vilardell, F., Salud, A., Montal, R.
Publikováno v:
In Annals of Oncology June 2023 34 Supplement 1:S1-S1
Autor:
Kudo M; Department of Gastroenterology and Hepatology, Kindai University Faculty of Medicine, Osaka, Japan., Montal R; Department of Medical Oncology, Cancer Biomarkers Research Group, Hospital Universitari Arnau de Vilanova - IRBLleida, Lleida, Catalonia, Spain.; Liver Cancer Translational Research Group, Liver Unit, IDIBAPS, Hospital Clinic University of Barcelona, Barcelona, Catalonia, Spain., Finn RS; Division of Hematology/Oncology, University of California, Los Angeles, California., Castet F; Liver Cancer Translational Research Group, Liver Unit, IDIBAPS, Hospital Clinic University of Barcelona, Barcelona, Catalonia, Spain., Ueshima K; Department of Gastroenterology and Hepatology, Kindai University Faculty of Medicine, Osaka, Japan., Nishida N; Department of Gastroenterology and Hepatology, Kindai University Faculty of Medicine, Osaka, Japan., Haber PK; Mount Sinai Liver Cancer Program, Division of Liver Diseases, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York., Hu Y; ROCHE, Basel, Switzerland., Chiba Y; Clinical Research Center, Division of Biostatistics, Kindai University Hospital, Osaka, Japan., Schwartz M; Mount Sinai Liver Cancer Program, Division of Liver Diseases, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York., Meyer T; UCL Cancer Institute, University College London, London, United Kingdom.; Royal Free Hospital, London, United Kingdom., Lencioni R; University of Pisa School of Medicine, Pisa, Italy.; Miami Cancer Institute, Miami, Florida., Llovet JM; Liver Cancer Translational Research Group, Liver Unit, IDIBAPS, Hospital Clinic University of Barcelona, Barcelona, Catalonia, Spain.; Mount Sinai Liver Cancer Program, Division of Liver Diseases, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York.; Institucio Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Catalonia, Spain.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2022 Aug 15; Vol. 28 (16), pp. 3443-3451.